Healthcare Equipment and Supplies
Company Overview of Ethicon Endo-Surgery, Inc.
Ethicon Endo-Surgery, Inc. develops and markets medical devices for minimally invasive and open surgical procedures worldwide. It provides access devices, such as trocars, insufflation needles, and hand assisted and single site laparoscopy devices; clip appliers, including endoscopic rotating multiple clip appliers, open ligation products, and multi-patient use single-clip appliers; and specimen retrieval bags, suturing devices, endoscopic hand instruments, electrosurgical and irrigation products, laparoscopic bipolar forceps, and uterine manipulators. The company offers energy devices, such as curved and long curved shears, blades, open shears, jaw tissue sealers, and curved and straight ti...
4545 Creek Road
Cincinnati, OH 45242-2839
Founded in 1992
Key Executives for Ethicon Endo-Surgery, Inc.
Compensation as of Fiscal Year 2015.
Ethicon Endo-Surgery, Inc. Key Developments
U.S. District Court Grants Covidien Preliminary Injunction against Ethicon Endo-Surgery, Inc.'s Harmonic ACE+7
Oct 17 14
Covidien plc announced that the U.S. District Court for the District of Connecticut has granted a preliminary injunction against Ethicon Endo-Surgery, Inc. This injunction results from a lawsuit filed by Covidien in June 2014 that alleges Ethicon's latest ultrasonic surgical product, the Harmonic ACE+7, infringes three Covidien patents. The injunction prevents Ethicon from manufacturing, marketing and selling the Harmonic ACE+7. The June 2014 lawsuit contends that U.S. Patents 6,063,050; 6,468,286; and 6,682,544 are infringed by Ethicon's Harmonic ACE+7 Shears. Ethicon's Harmonic devices were found to infringe the same patents in a prior suit in the same court that resulted in a damages award against Ethicon of more than $175 million, a finding that is currently under appeal.
Ethicon Endo-Surgery, Inc. Announces Launch of New Ultrasonic Surgical Device
Aug 4 14
Ethicon Endo-Surgery, Inc. has announced the launch of HARMONIC FOCUS+ Shears with Adaptive Tissue Technology, a next generation ultrasonic surgical device. The new HARMONIC FOCUS+ features the proprietary Adaptive Tissue Technology that Ethicon introduced in HARMONIC ACE+ last year, integrated into a new, slimmer design with faster sealing and transaction at the tip for greater precision and speed. Next-generation Adaptive Tissue Technology enables HARMONIC FOCUS+ to actively sense and adapt to changing tissue conditions to intelligently deliver energy, resulting in reduced clamp arm temperature for improved thermal management; a redesigned tip profile on HARMONIC FOCUS+ delivers 49% faster sealing and cutting at the tip; the HARMONIC FOCUS Shears reduces procedure time in long and complex procedures; and a newly designed profile that is 19% slimmer for improved visualization. HARMONIC FOCUS+ is designed for use in specialties including otorhinolaryngologic (ENT), and General Surgery and in open procedures requiring fine dissection and reliable vessel sealing. HARMONIC FOCUS+ will be available beginning this month in the US, most of Western Europe, Canada, Australia, and New Zealand. This device is the just the latest in a series of technology advancements from the Ethicon Energy platform including HARMONIC ACE+7 Shears with Advanced Hemostasis and the ENSEAL G2 Articulating Tissue Sealer.
Covidien Files Patent Infringement Lawsuit over Ethicon Endo-Surgery, Inc.'s Ultrasonic Surgical Devices
Jun 24 14
Covidien announced that it filed a lawsuit in the U.S. District Court for the District of Connecticut against Ethicon Endo-Surgery, Inc. The lawsuit alleges that Ethicon's latest ultrasonic surgical product, the Harmonic ACE(R)+7, infringes three Covidien patents. The same federal court found that these patents were valid and had been infringed in an earlier lawsuit relating to other Ethicon ultrasonic surgical products. The lawsuit contends that U.S. Patents 6,063,050; 6,468,286; and 6,682,544 are infringed by Ethicon's Harmonic ACE(R)+7 Shears. Ethicon's Harmonic devices were found to infringe the same patents in a prior suit in the same court that resulted in a damages award against Ethicon of more than $175 million, a finding that is currently under appeal. The new suit asks the court to enjoin Ethicon from continuing to make and sell the Harmonic ACE(R)+7 device and to grant damages for the patent infringement.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|